Publication Date |
2016 |
Page Count |
23 |
Abstract |
Insomnia is linked to impaired cognitive and immune functions, decreased quality of life, and increased accidents. Insomnia is well established in the general population both as a risk factor for and as a symptom PTSD, anxiety, and depression. CBT-I and pharmacotherapies are both efficacious treatments for the improvement of sleep. However, CBT-I is often time-consuming, requires trained clinicians or health care providers, and is not readily accessible. CBT-I requires that individuals keep a consistent daily sleep and wake schedule, which would be difficult for Service members deployed in war zones. Hypnotic drugs have undesirable side effects and are recommended primarily for a short-term use. These drugs are not ideal in a fast-paced environment with unpredictable sleeping conditions. Few data are available regarding soldiers with insomnia and no studies are available using a safe, portable device such as the CES in treatment of soldiers with insomnia. Hence, identification of insomnia and early treatment with a readily available, easy-to-use device with minimal adverse effects by military nurses and other healthcare providers can ensure timely treatment of soldiers with insomnia. This pilot study of treatment effect of CES is a first step in the development of research program with potential to assist in the management of insomnia and co-morbid conditions in soldiers. |
Keywords |
|
Source Agency |
|
NTIS Subject Category |
|
Corporate Authors |
The Geneva Foundation, Tacoma, WA.; TriService Nursing Research Program, Bethesda, MD. |
Document Type |
Technical Report |
Title Note |
Final rept., 1 Aug. 2011 - 31 March 2016. |
NTIS Issue Number |
201703 |